| scholarly article | Q13442814 |
| P2093 | author name string | Mark C Chappell | |
| P2860 | cites work | Differential expression of nuclear AT1 receptors and angiotensin II within the kidney of the male congenic mRen2. Lewis rat | Q82224054 |
| Simultaneous determination of angiotensins II and 1-7 by capillary zone electrophoresis in plasma and urine from hypertensive rats | Q82882319 | ||
| Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin-angiotensin-aldosterone system activity and the efficacy of renin-angiotensin-aldosterone system blockade in the kidney | Q84975913 | ||
| Characterization of the renal renin-angiotensin system in transgenic mice that express rat tonin | Q85659482 | ||
| Identification of bona fide alternative renin transcripts expressed along cortical tubules and potential roles in promoting insulin resistance in vivo without significant plasma renin activity elevation | Q87775417 | ||
| A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase | Q22254730 | ||
| Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism | Q24300310 | ||
| A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme | Q24306614 | ||
| Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas | Q24680069 | ||
| Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart | Q28114921 | ||
| Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril | Q28215905 | ||
| The human plasma proteome: history, character, and diagnostic prospects | Q28218148 | ||
| Genetic and molecular properties of human and rat renin-binding proteins with reference to the function of the leucine zipper motif | Q28283942 | ||
| High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells | Q28568580 | ||
| Intrarenal angiotensin III is the predominant agonist for proximal tubule angiotensin type 2 receptors | Q28569701 | ||
| Release of angiotensin-(1-7) from the rat hindlimb: influence of angiotensin-converting enzyme inhibition | Q28573604 | ||
| Mechanism of high glucose induced angiotensin II production in rat vascular smooth muscle cells | Q28575138 | ||
| High-glucose-induced regulation of intracellular ANG II synthesis and nuclear redistribution in cardiac myocytes | Q28582700 | ||
| Angiotensin II generation by mast cell alpha- and beta-chymases | Q28610117 | ||
| Subcellular characteristics of functional intracellular renin-angiotensin systems. | Q30417227 | ||
| Identification and characterization of a functional mitochondrial angiotensin system | Q30427934 | ||
| Intrarenal angiotensin III infusion induces natriuresis and angiotensin type 2 receptor translocation in Wistar-Kyoto but not in spontaneously hypertensive rats | Q30437186 | ||
| Renal vasoconstrictor and pressor responses to angiotensin IV in mice are AT1a-receptor mediated. | Q30882409 | ||
| Activation of a local tissue angiotensin system in podocytes by mechanical strain | Q33195945 | ||
| Novel mass spectrometric methods for evaluation of plasma angiotensin converting enzyme 1 and renin activity | Q33221785 | ||
| Renal cathepsin G and angiotensin II generation | Q33254296 | ||
| Mass-spectrometric identification of a novel angiotensin peptide in human plasma. | Q33265175 | ||
| Angiotensin-(1-7)-angiotensin-converting enzyme 2 attenuates reactive oxygen species formation to angiotensin II within the cell nucleus | Q33652507 | ||
| Effects of exercise training on circulating and skeletal muscle renin-angiotensin system in chronic heart failure rats | Q33654750 | ||
| Development and evaluation of an immuno-MALDI (iMALDI) assay for angiotensin I and the diagnosis of secondary hypertension | Q33845414 | ||
| Chronic AT2 receptor activation increases renal ACE2 activity, attenuates AT1 receptor function and blood pressure in obese Zucker rats | Q33881270 | ||
| Influence of estrogen depletion and salt loading on renal angiotensinogen expression in the mRen(2).Lewis strain. | Q33995050 | ||
| Chymase-dependent generation of angiotensin II from angiotensin-(1-12) in human atrial tissue | Q34105211 | ||
| Mass spectrometry for the molecular imaging of angiotensin metabolism in kidney | Q34154249 | ||
| Nuclear angiotensin-(1–7) receptor is functionally coupled to the formation of nitric oxide | Q34305539 | ||
| The ins and outs of angiotensin processing within the kidney | Q34428940 | ||
| Glucocorticoid-induced fetal programming alters the functional complement of angiotensin receptor subtypes within the kidney | Q34586584 | ||
| Angiotensin-(1-7) abolishes AGE-induced cellular hypertrophy and myofibroblast transformation via inhibition of ERK1/2. | Q34623871 | ||
| Captopril avoids hypertension, the increase in plasma angiotensin II but increases angiotensin 1-7 and angiotensin II-induced perfusion pressure in isolated kidney in SHR. | Q34642815 | ||
| The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. | Q34690091 | ||
| Proteolytic processing of angiotensin-I in human blood plasma | Q34749409 | ||
| Nuclear expression of renin-angiotensin system components in NRK-52E renal epithelial cells | Q34772555 | ||
| Intratubular renin-angiotensin system in hypertension | Q34777649 | ||
| Intrarenal angiotensin II and its contribution to the genesis of chronic hypertension. | Q34785905 | ||
| Commercially available angiotensin II At₂ receptor antibodies are nonspecific. | Q34809342 | ||
| Intracellular sorting of renin: cell type specific differences and their consequences | Q35035369 | ||
| New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II | Q35109349 | ||
| An angiotensin-(1-7) peptidase in the kidney cortex, proximal tubules, and human HK-2 epithelial cells that is distinct from insulin-degrading enzyme | Q35178620 | ||
| Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes. | Q35229766 | ||
| Aerobic exercise training-induced left ventricular hypertrophy involves regulatory MicroRNAs, decreased angiotensin-converting enzyme-angiotensin ii, and synergistic regulation of angiotensin-converting enzyme 2-angiotensin (1-7). | Q35251166 | ||
| Increased renin excretion is associated with augmented urinary angiotensin II levels in chronic angiotensin II-infused hypertensive rats | Q35601621 | ||
| Novel roles of nuclear angiotensin receptors and signaling mechanisms | Q35850244 | ||
| Lessons from in vitro studies and a related intracellular angiotensin II transgenic mouse model | Q35850265 | ||
| Divergent pathways for the angiotensin-(1-12) metabolism in the rat circulation and kidney | Q36005135 | ||
| Roles of collecting duct renin and (pro)renin receptor in hypertension: mini review | Q36029685 | ||
| Differential regulation of circulating and renal ACE2 and ACE in hypertensive mRen2.Lewis rats with early-onset diabetes. | Q36042210 | ||
| Role of angiotensin III in hypertension | Q36062241 | ||
| Diabetic Nephropathy Induced by Increased Ace Gene Dosage Is Associated with High Renal Levels of Angiotensin (1-7) and Bradykinin | Q36084248 | ||
| Renin/prorenin receptors | Q36467820 | ||
| Lack of specificity of commercial antibodies leads to misidentification of angiotensin type 1 receptor protein | Q36470843 | ||
| Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease | Q36511499 | ||
| G-protein-coupled receptors, channels, and Na+-H+ exchanger in nuclear membranes of heart, hepatic, vascular endothelial, and smooth muscle cells | Q36562742 | ||
| Plasma and Kidney Angiotensin Peptides: Importance of the Aminopeptidase A/Angiotensin III Axis | Q36591728 | ||
| Emerging evidence for a functional angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS receptor axis: more than regulation of blood pressure? | Q36929193 | ||
| Urinary angiotensinogen as a potential biomarker of severity of chronic kidney diseases | Q36951760 | ||
| Determination of plasma and urinary angiotensinogen levels in rodents by newly developed ELISA | Q37029541 | ||
| Functional role, cellular source, and tissue distribution of rat elastase-2, an angiotensin II-forming enzyme | Q44417039 | ||
| Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP). | Q44518988 | ||
| NADPH oxidase and enhanced superoxide generation in intrauterine undernourished rats: involvement of the renin-angiotensin system | Q44590322 | ||
| Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme Homologue ACE2. | Q44592757 | ||
| Effect of reduced angiotensin-converting enzyme gene expression and angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptide levels in mice | Q44760479 | ||
| True versus immunoreactive angiotensin II in human plasma. | Q45018550 | ||
| Conversion of renin substrate tetradecapeptide to angiotensin II by rat MAB elastase-2. | Q45220362 | ||
| Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects | Q45276776 | ||
| Quenched fluorescent substrate-based peptidase assays | Q46619369 | ||
| Orally active aminopeptidase A inhibitors reduce blood pressure: a new strategy for treating hypertension | Q46686052 | ||
| Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors | Q46749509 | ||
| ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes | Q46782071 | ||
| Evidence supporting a functional role for intracellular renin in the brain | Q46919174 | ||
| Immunocapture-based fluorometric assay for the measurement of neprilysin-specific enzyme activity in brain tissue homogenates and cerebrospinal fluid | Q46975126 | ||
| Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats | Q48218404 | ||
| Angiotensin-converting enzyme 2 and angiotensin-(1-7): an evolving story in cardiovascular regulation | Q48561334 | ||
| Reassessment of plasma angiotensins measurement: Effects of protease inhibitors and sample handling procedures | Q48667993 | ||
| Development of a sensitive, accurate and robust liquid chromatography/mass spectrometric method for profiling of angiotensin peptides in plasma and its application for atherosclerotic mice. | Q50995177 | ||
| Depletion of tissue angiotensin-converting enzyme differentially influences the intrarenal and urinary expression of angiotensin peptides. | Q51022226 | ||
| Chymase inhibitor-sensitive synthesis of endothelin-1 (1-31) by recombinant mouse mast cell protease 4 and human chymase. | Q51581806 | ||
| Angioprotectin: an angiotensin II-like peptide causing vasodilatory effects. | Q51767518 | ||
| Circulating activities of angiotensin-converting enzyme, its homolog, angiotensin-converting enzyme 2, and neprilysin in a family study. | Q52855193 | ||
| Isolation and identification of proangiotensin-12, a possible component of the renin-angiotensin system. | Q53593286 | ||
| Influence of atorvastatin on angiotensin I metabolism in resting and TNF-α -activated rat vascular smooth muscle cells. | Q54272885 | ||
| Reproducibility crisis: Blame it on the antibodies | Q59060328 | ||
| Angiotensin II and 1-7 during aging in Metabolic Syndrome rats. Expression of AT1, AT2 and Mas receptors in abdominal white adipose tissue | Q60642125 | ||
| Pressor and Renal Hemodynamic Effects of the Novel Angiotensin A Peptide Are Angiotensin II Type 1A Receptor Dependent | Q62021723 | ||
| Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell. | Q64947865 | ||
| Angiotensinases restrict locally generated angiotensin II to the blood vessel wall. | Q64964448 | ||
| An alternative strategy for the radioimmunoassay of angiotensin peptides using amino-terminal-directed antisera: measurement of eight angiotensin peptides in human plasma | Q68480065 | ||
| Identification and quantitation of angiotensins | Q68994496 | ||
| Direct evidence for local generation and release of angiotensin II in human vascular tissue | Q69557322 | ||
| Identification of angiotensin-(1-7) in rat brain. Evidence for differential processing of angiotensin peptides | Q69723243 | ||
| Measurement of immunoreactive angiotensin peptides in rat tissues: some pitfalls in angiotensin II analysis | Q69847788 | ||
| An improved fluorometric assay of rat serum and plasma converting enzyme | Q70081071 | ||
| Nephrectomy, converting enzyme inhibition, and angiotensin peptides | Q70497498 | ||
| Angiotensin II formation in dog heart is mediated by different pathways in vivo and in vitro | Q71435907 | ||
| Angiotensin peptides in spontaneously hypertensive and normotensive Donryu rats | Q72210820 | ||
| Observations on the origin of renin in human urine | Q72351824 | ||
| Angiotensin I Conversion by Human and Rat Chymotryptic Proteinases | Q72398088 | ||
| Cardiac interstitial fluid levels of angiotensin I and II in the pig | Q73513629 | ||
| Increased cardiac angiotensin II levels induce right and left ventricular hypertrophy in normotensive mice | Q73699605 | ||
| Characterization of angiotensin-(1-7) in the urine of normal and essential hypertensive subjects | Q74385757 | ||
| HPLC in the analysis of peptide metabolism | Q75220527 | ||
| Adrenal, kidney, and heart angiotensins in female murine Ren-2 transfected hypertensive rats | Q77764371 | ||
| Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II | Q80077979 | ||
| Association of somatic and N-domain angiotensin-converting enzymes from Wistar rat tissue with renal dysfunction in diabetes mellitus | Q80288683 | ||
| Long-term AT1 receptor blockade improves metabolic function and provides renoprotection in Fischer-344 rats | Q80580056 | ||
| Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients | Q37135790 | ||
| Distinct roles for angiotensin-converting enzyme 2 and carboxypeptidase A in the processing of angiotensins within the murine heart | Q37175696 | ||
| Augmentation of endogenous intrarenal angiotensin II levels in Val5-ANG II-infused rats | Q37190278 | ||
| The angiotensin II-AT1 receptor stimulates reactive oxygen species within the cell nucleus | Q37208119 | ||
| Nuclear angiotensin II type 2 (AT2) receptors are functionally linked to nitric oxide production | Q37216933 | ||
| Evidence for a functional intracellular angiotensin system in the proximal tubule of the kidney | Q37324997 | ||
| Detecting low-abundance vasoactive peptides in plasma: progress toward absolute quantitation using nano liquid chromatography-mass spectrometry. | Q37350114 | ||
| Association of elevated urinary concentration of renin-angiotensin system components and severe AKI. | Q37359056 | ||
| Compartmentalization of angiotensin II generation in the dog heart. Evidence for independent mechanisms in intravascular and interstitial spaces | Q37369862 | ||
| A renin transcript lacking exon 1 encodes for a non-secretory intracellular renin that increases aldosterone production in transgenic rats | Q37398281 | ||
| Estimation of angiotensin peptides in biological samples by LC/MS method | Q37523322 | ||
| Novel role of aminopeptidase-A in angiotensin-(1-7) metabolism post myocardial infarction | Q37656079 | ||
| Mast cell proteases as protective and inflammatory mediators | Q37895550 | ||
| New cardiovascular and pulmonary therapeutic strategies based on the Angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor axis | Q37982718 | ||
| The intracrine renin-angiotensin system | Q38010459 | ||
| Angiotensin II generation in vivo: does it involve enzymes other than renin and angiotensin-converting enzyme? | Q38012946 | ||
| Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system. | Q38054993 | ||
| Urinary markers of intrarenal renin-angiotensin system activity in vivo | Q38072329 | ||
| Angiotensin-(1-7). | Q38198985 | ||
| Recent insights and therapeutic perspectives of angiotensin-(1-9) in the cardiovascular system. | Q38230104 | ||
| MAS and its related G protein-coupled receptors, Mrgprs. | Q38253170 | ||
| Hypertension: renin-angiotensin-aldosterone system alterations | Q38376304 | ||
| Discovery and characterization of alamandine: a novel component of the renin-angiotensin system | Q39187631 | ||
| Cytosolic renin is targeted to mitochondria and induces apoptosis in H9c2 rat cardiomyoblasts | Q39955247 | ||
| Intrarenal production of angiotensin II. | Q41605108 | ||
| Angiotensin-(1-7) prevents systemic hypertension, attenuates oxidative stress and tubulointerstitial fibrosis, and normalizes renal angiotensin-converting enzyme 2 and Mas receptor expression in diabetic mice | Q41704433 | ||
| Absolute quantification of endogenous angiotensin II levels in human plasma using ESI-LC-MS/MS. | Q41995755 | ||
| Effects of a domain-selective ACE inhibitor in a mouse model of chronic angiotensin II-dependent hypertension | Q42229346 | ||
| Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats | Q42515936 | ||
| Renal interstitial fluid angiotensin I and angiotensin II concentrations during local angiotensin-converting enzyme inhibition | Q42525086 | ||
| Functional intracellular renin-angiotensin systems: potential for pathophysiology of disease | Q42570286 | ||
| Recombinant Expression and Characterization of Human and Murine ACE2: Species-Specific Activation of the Alternative Renin-Angiotensin-System | Q42589155 | ||
| High sucrose intake in rats is associated with increased ACE2 and angiotensin-(1-7) levels in the adipose tissue. | Q43117155 | ||
| Gene knockout of insulin-regulated aminopeptidase: loss of the specific binding site for angiotensin IV and age-related deficit in spatial memory | Q43297455 | ||
| Measurement of immunoreactive angiotensin-(1-7) heptapeptide in human blood. | Q43556507 | ||
| Big angiotensin-25: a novel glycosylated angiotensin-related peptide isolated from human urine | Q43799197 | ||
| Intrarenal angiotensin II: interstitial and cellular levels and site of production | Q43818237 | ||
| P433 | issue | 2 | |
| P304 | page(s) | H137-52 | |
| P577 | publication date | 2015-10-16 | |
| P1433 | published in | American Journal of Physiology Heart and Circulatory Physiology | Q3193662 |
| P1476 | title | Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute? | |
| P478 | volume | 310 |
| Q52651593 | A Brief Introduction into the Renin-Angiotensin-Aldosterone System: New and Old Techniques. |
| Q37738188 | A Fluorometric Method of Measuring Carboxypeptidase Activities for Angiotensin II and Apelin-13 |
| Q59794194 | A Genomic Survey of Angiotensin-Converting Enzymes Provides Novel Insights into Their Molecular Evolution in Vertebrates |
| Q51004393 | A Primer to Angiotensin Peptide Isolation, Stability, and Analysis by Nano-Liquid Chromatography with Mass Detection. |
| Q91723901 | ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway |
| Q47231226 | Angiotensin II Receptor-Neprilysin Inhibitor Sacubitril/Valsartan Improves Endothelial Dysfunction in Spontaneously Hypertensive Rats |
| Q89006965 | Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology |
| Q39105761 | Angiotensin II reduces the surface abundance of KV 1.5 channels in arterial myocytes to stimulate vasoconstriction. |
| Q52354923 | Angiotensin-(1-7) and Alamandine on Experimental Models of Hypertension and Atherosclerosis. |
| Q88481204 | Angiotensin-(1-7) and the Regulation of Anti-Fibrotic Signaling Pathways |
| Q64058386 | Angiotensin-(1-7) inhibits sodium transport via Mas receptor by increasing nitric oxide production in thick ascending limb |
| Q51140047 | Angiotensin-(1-7)-dependent vasorelaxation of the renal artery exhibits unique angiotensin and bradykinin receptor selectivity. |
| Q90119066 | Angiotensin-[1-7] attenuates kidney injury in experimental Alport syndrome |
| Q38728236 | Angiotensinogen import in isolated proximal tubules: evidence for mitochondrial trafficking and uptake |
| Q51004407 | Assessment of the Renin-Angiotensin System in Cellular Organelle: New Arenas for Study in the Mitochondria. |
| Q58794520 | Association between preterm birth and the renin-angiotensin system in adolescence: influence of sex and obesity |
| Q89849258 | Association of Angiotensin I Converting Enzyme Insertion/287 bp Deletion Polymorphisms and Proliferative Prostatic Diseases among Lebanese Men |
| Q94452428 | Association of circulating uric acid and angiotensin-(1-7) in relation to higher blood pressure in adolescents and the influence of preterm birth |
| Q37183375 | Association of exercise training and angiotensin-converting enzyme 2 activator improves baroreflex sensitivity of spontaneously hypertensive rats |
| Q48124340 | Blood capillary rarefaction and lymphatic capillary neoangiogenesis are key contributors to renal allograft fibrosis in an ACE inhibition rat model. |
| Q37284274 | Brain Formaldehyde is Related to Water Intake behavior |
| Q90387099 | Caffeine in Kidney Stone Disease: Risk or Benefit? |
| Q90265122 | Causes and Consequences of the Dysregulated Maternal Renin-Angiotensin System in Preeclampsia |
| Q51343625 | Chymase-dependent production of angiotensin II: an old enzyme in old hearts. |
| Q36310511 | Circulating progenitor cells in hypertensive subjects: Effectiveness of a treatment with olmesartan in improving cell number and miR profile in addition to expected pharmacological effects |
| Q58576263 | Comparative Expression of Renin-Angiotensin Pathway Proteins in Visceral Versus Subcutaneous Fat |
| Q92710285 | Counter-regulatory renin-angiotensin system in cardiovascular disease |
| Q98945458 | Endoplasmic Reticulum (ER) Stress in Part Mediates Effects of Angiotensin II in Pancreatic Beta Cells |
| Q38776339 | Endothelial Dysfunction and Hypertension |
| Q36775670 | Evidence for a mitochondrial angiotensin-(1-7) system in the kidney |
| Q38679303 | Future drug discovery in renin-angiotensin-aldosterone system intervention |
| Q47299277 | Hypertension regulating angiotensin peptides in the pathobiology of cardiovascular disease. |
| Q40952939 | Identification of dipeptidyl peptidase 3 as the Angiotensin-(1-7) degrading peptidase in human HK-2 renal epithelial cells |
| Q39268286 | Impact of Non-Human Leukocyte Antigen-Specific Antibodies in Kidney and Heart Transplantation |
| Q89256643 | Inappropriate activity of local renin-angiotensin-aldosterone system during high salt intake: impact on the cardio-renal axis |
| Q49890916 | Intracrine action of angiotensin II in mesangial cells: subcellular distribution of angiotensin II receptor subtypes AT1 and AT2. |
| Q38846247 | Intracrine angiotensin II functions originate from noncanonical pathways in the human heart |
| Q54672977 | Letter to the editor: Angiotensin quantification by mass spectrometry. |
| Q64987203 | Losartan and isoproterenol promote alterations in the local renin-angiotensin system of rat salivary glands. |
| Q33851446 | Measurement of Angiotensin Peptides: HPLC-RIA. |
| Q37271294 | Neprilysin is a Mediator of Alternative Renin-Angiotensin-System Activation in the Murine and Human Kidney |
| Q52099112 | No Brain Renin-Angiotensin System: Déjà vu All Over Again? |
| Q30235583 | Novel Cardiac Intracrine Mechanisms Based on Ang-(1-12)/Chymase Axis Require a Revision of Therapeutic Approaches in Human Heart Disease |
| Q58611009 | Obesity is Associated with Higher Blood Pressure and Higher Levels of Angiotensin II but Lower Angiotensin-(1-7) in Adolescents Born Preterm |
| Q49566048 | Regulation, signalling and functions of hormonal peptides in pulmonary vascular remodelling during hypoxia |
| Q38750210 | Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease |
| Q98771893 | Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review |
| Q97536710 | SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy |
| Q39050197 | Serum protease activity in chronic kidney disease patients: The GANI_MED renal cohort |
| Q98227509 | Snake venom-derived bradykinin-potentiating peptides: A promising therapy for COVID-19? |
| Q48345925 | Stabilization of Angiotensin-(1-7) by key substitution with a cyclic non-natural amino acid. |
| Q33645806 | The ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Pleiotropic Roles in Cancer |
| Q51767571 | The Role of Renin-Angiotensin-Aldosterone System and Its New Components in Arterial Stiffness and Vascular Aging. |
| Q59353397 | The renin angiotensin system in liver and lung: impact and therapeutic potential in organ fibrosis |
| Q64101852 | The renin-angiotensin-aldosterone system and its suppression |
| Q39376362 | The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases. |
| Q38694797 | Validation of commercial Mas receptor antibodies for utilization in Western Blotting, immunofluorescence and immunohistochemistry studies |
Search more.